RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 79 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,860,000 | -59.1% | 491,700 | -18.0% | 0.24% | -56.6% |
| Q2 2019 | $9,438,000 | -19.8% | 600,000 | -7.7% | 0.54% | -31.8% |
| Q1 2019 | $11,765,000 | +102.7% | 650,000 | +80.1% | 0.80% | +68.8% |
| Q4 2018 | $5,803,000 | -33.7% | 360,910 | -1.0% | 0.47% | -17.2% |
| Q3 2018 | $8,749,000 | – | 364,559 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |